|
WHO Model List of Essential Medicines (2021)
|
6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors
|
No observations
|
|
Peru
|
6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors
|
No observations
|
|
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública.
|
CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública.
|
Others observations:
x 60 TAB
|
|
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health.
|
Anti-Retroviral Treatment Programme
|
No observations
|
|
Costa Rica. Caja Costarricense de Seguro Social. 2019
|
04. Antifungicos y Antivirales
|
No observations
|
|
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015
|
07.07 ANTIVIRALS
|
No observations
|
|
Mexico. Cuadro Basico de Medicamentos - 2017
|
06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS
|
No observations
|
|
Brasil. Relação Nacional de Medicamentos Essenciais. 2020
|
J. ANTI-INFECCIOSOS PARA USO SISTEMICO
|
No observations
|
|
Paraguay. Lista de Medicamentos Esenciales. 2009
|
05. ANTIVIRALES DE USO SISTÉMICO
|
No observations
|
|
El Salvador - 2019
|
ANTIVIRALES DE USO SISTÉMICO
|
No observations
|
|
Chile. Formulario Nacional de Medicamentos. 2005
|
06.05. ANTIVIRALES
|
No observations
|
|
Guyana. Essential Medicines List. 2020-2021
|
7.09.02.01. Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
|
No observations
|
|
Bahamas. Drug Formulary
|
07.03.01. Anti-Retroviral (ARV) Agents
|
No observations
|
